Reply to Farkouh RA et al. Comment on "Cost-Effectiveness Evaluation of the 10-Valent Pneumococcal Non-Typeable Haemophilus Influenzae Protein D Conjugate Vaccine and 13-Valent Pneumococcal Vaccine in Japanese Children".
作者信息
Shiragami Makoto, Mizukami Akiko, Leeuwenkamp Oscar, Mrkvan Tomas, Delgleize Emmanuelle, Kurono Yuichi, Iwata Satoshi
机构信息
Social and Administrative Pharmacy Science, School of Pharmacy, Nihon University, Funabashi-shi, Chiba, Japan.
出版信息
Infect Dis Ther. 2015 Jun;4(2):235-44. doi: 10.1007/s40121-015-0062-1. Epub 2015 Apr 24.
Abstract
摘要
相似文献
1
Reply to Farkouh RA et al. Comment on "Cost-Effectiveness Evaluation of the 10-Valent Pneumococcal Non-Typeable Haemophilus Influenzae Protein D Conjugate Vaccine and 13-Valent Pneumococcal Vaccine in Japanese Children".对法尔库赫·拉等人的回复。关于“10价肺炎球菌非分型流感嗜血杆菌蛋白D结合疫苗和13价肺炎球菌疫苗在日本儿童中的成本效益评估”的评论
Infect Dis Ther. 2015 Jun;4(2):235-44. doi: 10.1007/s40121-015-0062-1. Epub 2015 Apr 24.
2
Comment on: "Cost-Effectiveness Evaluation of the 10-Valent Pneumococcal Non-Typeable Haemophilus influenzae Protein D Conjugate Vaccine and 13-Valent Pneumococcal Vaccine in Japanese Children".关于《10价肺炎球菌非分型流感嗜血杆菌蛋白D结合疫苗与13价肺炎球菌疫苗在日本儿童中的成本效益评估》的评论
Infect Dis Ther. 2015 Jun;4(2):227-33. doi: 10.1007/s40121-015-0063-0. Epub 2015 Apr 24.
3
Safety, reactogenicity and immunogenicity of 2-dose catch-up vaccination with 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Malian children in the second year of life: Results from an open study.10价肺炎球菌非分型流感嗜血杆菌蛋白D结合疫苗（PHiD-CV）对马里第二年儿童进行2剂补种疫苗接种的安全性、反应原性和免疫原性：一项开放性研究的结果
Hum Vaccin Immunother. 2015;11(9):2207-14. doi: 10.1080/21645515.2015.1016679.
4
Cost-Effectiveness Evaluation of the 10-Valent Pneumococcal Non-typeable Haemophilus influenzae Protein D Conjugate Vaccine and 13-Valent Pneumococcal Vaccine in Japanese Children.10价肺炎球菌非分型流感嗜血杆菌蛋白D结合疫苗与13价肺炎球菌疫苗在日本儿童中的成本效益评估
Infect Dis Ther. 2014 Dec 20;4(1):93-112. doi: 10.1007/s40121-014-0053-7.
5
A Cost-Effectiveness Analysis of the 10-Valent Pneumococcal Non-Typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) Compared to the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) for Universal Mass Vaccination Implementation in New Zealand.新西兰全民推广使用 10 价肺炎球菌-无荚膜流感嗜血杆菌蛋白 D 结合疫苗（PHiD-CV）与 13 价肺炎球菌结合疫苗（PCV13）的成本效益分析
Appl Health Econ Health Policy. 2018 Jun;16(3):331-345. doi: 10.1007/s40258-018-0387-5.
6
Response to Wu et al. - Cost-effectiveness analysis of infant pneumococcal vaccination in Malaysia and Hong Kong.对吴等人的回应——马来西亚和香港婴儿肺炎球菌疫苗接种的成本效益分析
Hum Vaccin Immunother. 2016 Oct 2;12(10):2675-2680. doi: 10.1080/21645515.2016.1192738. Epub 2016 Jul 26.
7
Immunogenicity and safety of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) co-administered with DTPa vaccine in Japanese children: A randomized, controlled study.在日本儿童中10价肺炎球菌非分型流感嗜血杆菌蛋白D结合疫苗（PHiD-CV）与白喉破伤风无细胞百日咳疫苗（DTPa）联合接种的免疫原性和安全性：一项随机对照研究。
Hum Vaccin Immunother. 2015;11(4):826-37. doi: 10.1080/21645515.2015.1012019.
8
10-Valent pneumococcal non-typeable protein D conjugate vaccine (PHiD-CV10) versus 13-valent pneumococcal conjugate vaccine (PCV13) as a booster dose to broaden and strengthen protection from otitis media (PREVIX_BOOST) in Australian Aboriginal children: study protocol for a randomised controlled trial.10 价肺炎球菌无型蛋白 D 结合疫苗（PHiD-CV10）与 13 价肺炎球菌结合疫苗（PCV13）作为加强剂以扩大和增强对澳大利亚原住民儿童中耳炎的保护作用（PREVIX_BOOST）：一项随机对照试验研究方案。
BMJ Open. 2020 May 24;10(5):e033511. doi: 10.1136/bmjopen-2019-033511.
9
Reduced middle ear infection with non-typeable Haemophilus influenzae, but not Streptococcus pneumoniae, after transition to 10-valent pneumococcal non-typeable H. influenzae protein D conjugate vaccine.转换为10价肺炎球菌结合疫苗后，非分型流感嗜血杆菌引起的中耳感染减少，但肺炎链球菌引起的中耳感染未减少。
BMC Pediatr. 2015 Oct 19;15:162. doi: 10.1186/s12887-015-0483-8.
10
A cost-effectiveness analysis of PHiD-CV compared to PCV13 in a national immunization program setting in Tunisia.在突尼斯国家免疫规划背景下，对 PHiD-CV 与 PCV13 的成本效益进行分析。
Hum Vaccin Immunother. 2022 Nov 30;18(5):2079305. doi: 10.1080/21645515.2022.2079305. Epub 2022 Jun 15.
引用本文的文献
1
Clinical and Economic Impact of a Potential Switch from 13-Valent to 10-Valent Pneumococcal Conjugate Infant Vaccination in Canada.加拿大13价肺炎球菌结合疫苗转为10价肺炎球菌结合疫苗用于婴儿接种的潜在临床和经济影响
Infect Dis Ther. 2018 Sep;7(3):353-371. doi: 10.1007/s40121-018-0206-1. Epub 2018 Jun 22.
本文引用的文献
1
Comment on: "Cost-Effectiveness Evaluation of the 10-Valent Pneumococcal Non-Typeable Haemophilus influenzae Protein D Conjugate Vaccine and 13-Valent Pneumococcal Vaccine in Japanese Children".关于《10价肺炎球菌非分型流感嗜血杆菌蛋白D结合疫苗与13价肺炎球菌疫苗在日本儿童中的成本效益评估》的评论
Infect Dis Ther. 2015 Jun;4(2):227-33. doi: 10.1007/s40121-015-0063-0. Epub 2015 Apr 24.
2
Impact of ten-valent pneumococcal conjugate vaccination on invasive pneumococcal disease in Finnish children--a population-based study.十价肺炎球菌结合疫苗对芬兰儿童侵袭性肺炎球菌疾病的影响——一项基于人群的研究
PLoS One. 2015 Mar 17;10(3):e0120290. doi: 10.1371/journal.pone.0120290. eCollection 2015.
3
Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance.13 价肺炎球菌结合疫苗在儿童中的使用对美国儿童和成人侵袭性肺炎球菌病的影响：基于多地点、人群的监测分析。
Lancet Infect Dis. 2015 Mar;15(3):301-9. doi: 10.1016/S1473-3099(14)71081-3. Epub 2015 Feb 3.
4
Cost-Effectiveness Evaluation of the 10-Valent Pneumococcal Non-typeable Haemophilus influenzae Protein D Conjugate Vaccine and 13-Valent Pneumococcal Vaccine in Japanese Children.10价肺炎球菌非分型流感嗜血杆菌蛋白D结合疫苗与13价肺炎球菌疫苗在日本儿童中的成本效益评估
Infect Dis Ther. 2014 Dec 20;4(1):93-112. doi: 10.1007/s40121-014-0053-7.
5
All-cause pneumonia hospitalizations in children <2 years old in sweden, 1998 to 2012: impact of pneumococcal conjugate vaccine introduction.1998年至2012年瑞典2岁以下儿童全因性肺炎住院情况：肺炎球菌结合疫苗引入的影响
PLoS One. 2014 Nov 7;9(11):e112211. doi: 10.1371/journal.pone.0112211. eCollection 2014.
6
Predicting the impact of new pneumococcal conjugate vaccines: serotype composition is not enough.预测新肺炎球菌结合疫苗的影响：血清型组成还不够。
Expert Rev Vaccines. 2015 Mar;14(3):413-28. doi: 10.1586/14760584.2015.965160. Epub 2014 Sep 30.
7
Otitis media in children vaccinated during consecutive 7-valent or 10-valent pneumococcal conjugate vaccination schedules.在连续的7价或10价肺炎球菌结合疫苗接种程序中接种疫苗的儿童的中耳炎情况。
BMC Pediatr. 2014 Aug 11;14:200. doi: 10.1186/1471-2431-14-200.
8
Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study.13 价肺炎球菌结合疫苗的血清型特异性效力和保护相关性：上市后间接队列研究。
Lancet Infect Dis. 2014 Sep;14(9):839-46. doi: 10.1016/S1473-3099(14)70822-9. Epub 2014 Jul 17.
9
Impact of 13-valent pneumococcal conjugate vaccination in invasive pneumococcal disease incidence and mortality.13 价肺炎球菌结合疫苗对侵袭性肺炎球菌病发病率和死亡率的影响。
Clin Infect Dis. 2014 Oct 15;59(8):1066-73. doi: 10.1093/cid/ciu524. Epub 2014 Jul 16.
10
Further evidence for the effectiveness of PCV10 against Streptococcus pneumoniae serotype 19A.10价肺炎球菌结合疫苗（PCV10）对肺炎链球菌19A型有效力的进一步证据。
Lancet Respir Med. 2014 Jun;2(6):e7. doi: 10.1016/S2213-2600(14)70128-6.
Zotero 插件